10.10.16
NattoPharma, Oslo, Norway and Metuchen, NJ, has added industry veteran Collene Villalobos to its sales team.
Prior to joining Nattopharma as sales manager, Americas, Ms. Villalobos was a member of the Chromadex team for eight years. A graduate of Kansas State University with a degree in Biology, she joined the Chromadex team as a reference standards manager, managing all aspects of order fulfillment as well as the testing and qualification of new incoming materials and inventory. She later served as logistics and procurement manager directing products from ingredient to finished goods to retail fulfillment. She was then promoted to manage the Ingredient sales team, where she served the companies’ sales needs for several years.
“Collene has demonstrated success in ingredient validation and sales, thanks greatly to her technical understanding. She is an excellent addition to our growing sales team. With both current and new customers, Collene is well-positioned to communicate the compelling science behind our MenaQ7, the importance of partnering with the highest quality MK-7 provider, and the tremendous commercial opportunity that MenaQ7 represents to our customers,” said Dan Rosenbaum, NattoPharma CEO. “While our clinically validated and patented MenaQ7 appears in hundreds of products across the globe, we see extraordinary growth ahead as consumers around the world become increasingly aware of the proven health benefits of MenaQ7.”
Prior to joining Nattopharma as sales manager, Americas, Ms. Villalobos was a member of the Chromadex team for eight years. A graduate of Kansas State University with a degree in Biology, she joined the Chromadex team as a reference standards manager, managing all aspects of order fulfillment as well as the testing and qualification of new incoming materials and inventory. She later served as logistics and procurement manager directing products from ingredient to finished goods to retail fulfillment. She was then promoted to manage the Ingredient sales team, where she served the companies’ sales needs for several years.
“Collene has demonstrated success in ingredient validation and sales, thanks greatly to her technical understanding. She is an excellent addition to our growing sales team. With both current and new customers, Collene is well-positioned to communicate the compelling science behind our MenaQ7, the importance of partnering with the highest quality MK-7 provider, and the tremendous commercial opportunity that MenaQ7 represents to our customers,” said Dan Rosenbaum, NattoPharma CEO. “While our clinically validated and patented MenaQ7 appears in hundreds of products across the globe, we see extraordinary growth ahead as consumers around the world become increasingly aware of the proven health benefits of MenaQ7.”
